Larvol Delta - Meiji-Seika-Pharma-Receives-Approval-for-Adding-Domestic-Manufacturing-Sites-in-Japan-for-KOSTAIVE-a-Selfamplifying-mRNA-Vaccine-Against-COVID19

Kostaive (ARCT-154) - Arcturus Therap

https://www.businesswire.com/news/home/20250131312981/en/Meiji-Seika-Pharma-Receives-Approval-for-Adding-Domestic-Manufacturing-Sites-in-Japan-for-KOSTAIVE%C2%AE-a-Self-amplifying-mRNA-Vaccine-Against-COVID-19

Jan 31, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next